Screener
ARS Pharmaceuticals, Inc. SPRY Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The source filing: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 15, 2026, 6:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-225142
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Inventories | 8,817 | 8,369 |
| Prepaid expenses and other current assets | 6,788 | 6,194 |
| Total current assets | 245,236 | 284,896 |
| Inventories, noncurrent | 23,221 | 23,053 |
| Property, plant and equipment, net | 2,285 | 2,465 |
| Intangible assets, net | 14,176 | 14,452 |
| Other assets | 2,653 | 2,786 |
| Total assets | $287,571 | $327,652 |
Item 1. Financial Statements
FAQ
- What is ARS Pharmaceuticals, Inc.'s inventories?
- ARS Pharmaceuticals, Inc. (SPRY) reported inventories of $23.22M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s inventories changed year-over-year?
- ARS Pharmaceuticals, Inc.'s inventories increased by 94.5% year-over-year, from $11.94M to $23.22M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about ARS Pharmaceuticals, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude